I am an adult psychologist and my areas of research expertise include nicotine addiction and its treatment, including testing medications such as a nicotine vaccine and combination medications, in smokers at the Department of Psychiatry & Behavioral Sciences. I received a BA in Psychology from the University of California, Berkeley. I received a PhD in Clinical Psychology at the University of Minnesota and completed my internship at the University of Washington .
I am the Forster Family Chair in Cancer Prevention at the Masonic Cancer Center of the University of Minnesota and Professor of Psychiatry and Behavioral Sciences. I am the Associate Director of Cancer Prevention and Control at the University of Minnesota Masonic Cancer Center, Director of the Tobacco Research Programs and Deputy Director of the Global Institute for Research on Cancer Prevention.
Currently, I am PI/Co-PI of a large NIH-funded cooperative agreement and a program project grant that involves assessing the toxicity, appeal and addictiveness of various tobacco products, with the goal of reducing tobacco-caused harm and addiction. I have served on numerous scientific advisory boards for the U.S. government including the 1) Food and Drug Administration, Tobacco Product Scientific Advisory Committee, 2) National Advisory Council on Drug Abuse, 3) Interagency Committee on Smoking and Health, 4) Substance Abuse and Mental Health Services Administration, 5) Scientific Board of Counselors for the National Institutes on Drug Abuse, and 6) the Drug Control Research, Data and Evaluation Committee of the Office on National Drug Control Policy. I am currently a member of the World Health Organization Study Group on Tobacco Product Regulation and the National Cancer Institute, Board of Scientific Advisors.
- Tobacco Addiction
- Tobacco Regulatory Science
- Cancer Prevention
(for academic support only)
In the Media
- 2023: Featured in this U of M news story titled, "University of Minnesota Research Influences FDA Decision on Lower Nicotine Levels in Cigarettes", which was picked up by numerous news outlets.
Dr. Hatsukami's areas of research expertise are nicotine addiction and its treatment in smokers, including testing medications such as a nicotine vaccine and combination medications.
Dr. Hatsukami's clinical interests involve tobacco cessation.